ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000267374.1	Ponatinib	Bladder urothelial carcinoma	0.045964419	Resistant
ENSG00000267374.1	Ponatinib	Pancreatic adenocarcinoma	0.048749236	Resistant